On Monday, August 10, National Health Investors NHI will release its latest earnings report. Benzinga's outlook for National Health Investors is included in the following report.
Earnings and Revenue
Based on National Health Investors management projections, analysts predict EPS of $1.0 on revenue of $83.11 million. In the same quarter last year, National Health Investors reported earnings per share of $1.36 on revenue of $78.10 million. The analyst consensus estimate would represent a 26.47% decline in the company's EPS figure. Here's how the company's reported EPS has stacked up against analyst estimates in the past:
| Quarter | Q1 2020 | Q4 2020 | Q3 2019 | Q2 2019 |
|---|---|---|---|---|
| EPS Estimate | 0.95 | 0.94 | 0.95 | 0.95 |
| EPS Actual | 1.36 | 1.41 | 1.42 | 1.36 |
| Revenue Estimate | 83.09 M | 80.76 M | 80.29 M | 73.67 M |
| Revenue Actual | 83.08 M | 82.19 M | 81.68 M | 78.10 M |
Stock Performance
Over the past 52-week period, shares of National Health Investors have declined 21.73%. Given that these returns are generally negative, long-term shareholders are probably a little upset going into this earnings release.
Don't be surprised to see the stock move on comments made during its conference call. National Health Investors is scheduled to hold the call at 12:00:00 ET and can be accessed here: https://www.webcaster4.com/Webcast/Page/633/35812
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
